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The depression in force and/or velocity associatedwithmuscular fatigue can be the result of
a failure at any level, from the initial events in the motor cortex of the brain to the formation
of an actomyosin cross-bridge in the muscle cell. Since all the force and motion generated
by muscle ultimately derives from the cyclical interaction of actin and myosin, researchers
have focused heavily on the impact of the accumulation of intracellular metabolites [e.g.,
Pi, H+ and adenosine diphoshphate (ADP)] on the function these contractile proteins. At
saturating Ca++ levels, elevated Pi appears to be the primary cause for the loss in maximal
isometric force, while increased [H+] and possibly ADP act to slow unloaded shortening
velocity in single muscle ﬁbers, suggesting a causative role in muscular fatigue. However
the precise mechanisms through which these metabolites might affect the individual func-
tion of the contractile proteins remain unclear because intact muscle is a highly complex
structure. To simplify problem isolated actin and myosin have been studied in the in vitro
motility assay and more recently the single molecule laser trap assay with the ﬁndings
showing that both Pi and H+ alter single actomyosin function in unique ways. In addition
to these new insights, we are also gaining important information about the roles played by
the muscle regulatory proteins troponin (Tn) and tropomyosin (Tm) in the fatigue process.
In vitro studies, suggest that both the acidosis and elevated levels of Pi can inhibit velocity
and force at sub-saturating levels of Ca++ in the presence of Tn andTm and that this inhi-
bition can be greater than that observed in the absence of regulation. To understand the
molecular basis of the role of regulatory proteins in the fatigue process researchers are
taking advantage of modern molecular biological techniques to manipulate the structure
and function of Tn/Tm. These efforts are beginning to reveal the relevant structures and
how their functions might be altered during fatigue.Thus, it is a very exciting time to study
muscle fatigue because the technological advances occurring in the ﬁelds of biophysics
and molecular biology are providing researchers with the ability to directly test long held
hypotheses and consequently reshaping our understanding of this age-old question.
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INTRODUCTION
The quest to identify the cause(s) of muscle fatigue has been a
quintessential question in the ﬁeld of physiology for more than
100 years. In that time our understanding of the etiology of fatigue
has evolved greatly and we have a greater appreciation for the
complexity of the phenomenon, recognizing that there are many
potential factors that may contribute to fatigue. For example,
the rate and extent of fatigue is highly dependent of the mode
and intensity of contractility activity (Fitts, 1994). Based on these
observations it is now clear that, in general, the factors that cause
a muscle to fatigue from low intensity stimulation are distinctly
different from the factors that elicit fatigue from high intensity
stimulation (Fitts, 1994). This review focuses on the recent revela-
tions with regard to fatigue resulting from short and intense bouts
of contractile activity (i.e., high intensity fatigue) with a particular
focus on the role of the cross-bridge cycle. This type of muscle
fatigue was classically deﬁned by a decrease in force in response
to repeated intense contractile activity, however this deﬁnition has
been broadened to a decrease in the expected or required power
output (Fitts, 1994). This revision has two important implica-
tions; ﬁrstly it indicates that fatigue can occur at submaximal, as
well as maximal, contractile intensities; and secondly that fatigue
can result from a drop in force and/or the velocity of contraction.
This more widely accepted deﬁnition of fatigue now deﬁnes for
researchers in the ﬁeld the parameters on which to focus on or
identifying the underlying causes of this kind of transient loss of
muscle function.
Work in the late 1970s and early 1980s used NMR spectroscopy
on in vivomuscle to establish that the accumulation ofmetabolites,
principally hydrogen ions (H+, i.e., acidosis), inorganic phosphate
(Pi), and adenosine diphosphate (ADP), were correlated with the
development of fatigue in response to intense bouts of contrac-
tile activity (Dawson et al., 1978). Parallel efforts using chemically
skinned single muscle ﬁbers demonstrated that elevated levels of
these ions directly inhibit muscle’s ability to generate maximal
isometric force and unloaded shortening velocity (Cooke et al.,
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1988), providing strong evidence for a causative role in fatigue.
While it is clear from the skinned single muscle ﬁber studies
that elevated levels of metabolites directly affect the force and
motion generating capacity of muscle, it is still not clear how
this occurs at a molecular level. More sophisticated experiments
in single ﬁbers led to hypotheses about how these ions might
inhibit force and velocity at the level of a single cross-bridge
including how Pi might rebind to myosin and reverse the weak
to strong-binding transition (Hibberd et al., 1985; Dantzig et al.,
1992). Our current understanding of the role of the cross-bridge
cycle in fatigue based on muscle ﬁber experiments has recently
been reviewed (Fitts, 2008). In the present review we examine
the research at the molecular level largely incorporating in vitro
ﬁndings that provide more detailed insight into the underlying
mechanisms of putative agents of fatigue on actomyosin function.
The big advantage of using these methods is that the behav-
ior of a single cross-bridge can be directly observed rather than
inferred from the properties of a wholemuscle or even singlemus-
cle ﬁber where the parameters measured represent the collective
action of more than a billion individual cross-bridges. Further-
more, intact muscle contains a host of proteins in addition to
actin and myosin that act to modulate and regulate contractile
function, making it difﬁcult to isolate which proteins are medi-
ating the effects of fatigue. For these reasons researchers have
resorted to in vitro approaches to understand both which pro-
teins are involved and how the function of a single cross-bridge is
affected.
Great technological advances in the ﬁelds of biophysics and
molecular biology are now enabling researchers to gain unprece-
dented insight into some of the most fundamental mechanisms
underlying the loss of the force and motion generating capacities
of muscle during fatigue. It is these recent efforts that will be the
focus of this review. It is important to note that at the molecular
level the efforts to understand muscle fatigue are often conﬂu-
ent with the efforts to understand the basic molecular mechanism
of contraction and thus this review incorporates some literature
focused on the basic mechanism of contraction as it pertains to
understand fatigue.
THE CROSS-BRIDGE CYCLE
The force and motion generated by muscle are ultimately the
result of the cyclical interaction of myosin and actin in a process
coupled to the hydrolysis of ATP. This process, referred to as the
cross-bridge cycle, links myosin’s ATPase cycle with the mechan-
ical events that drive force and motion. Although many of the
speciﬁc details remain controversial, extensive study over many
years has provided a basic model for how a myosin molecule
converts the energy from ATP hydrolysis into force and motion
(Holmes and Geeves, 2000). This simple working model of the
cross-bridge cycle that incorporates the salient features of the cycle
can be used to explore the molecular basis of fatigue (Figure 1).
In this basic model, Pi-release is closely associated with myosin’s
lever arm rotation, the key molecular event responsible for force
and motion in muscle. This event is followed by two kinetic tran-
sitions that occur while myosin is strongly bound to actin. In the
ﬁrst step myosin, now strongly bound to actin, releases ADP from
the active site putting actomyosin in a rigor state; subsequently,
in the second step, the cross-bridge waits in a rigor state until a
new ATP molecule rebinds to myosin’s active site and facilitates
the dissociation from actin. While myosin is detached (or more
precisely weakly bound) from actin, ATP is hydrolyzed, a bio-
chemical event coupled to resetting of the lever arm, ensuring that
the next binding event causes another productive displacement. It
is important to point out that more complex models have been
proposed based on recent in vitro ﬁndings including additional
AM.ADP states that could be coupled to a structural change in
the position of the lever arm (Capitanio et al., 2006) and strongly
strongly bound pre-powerstroke states (Takagi et al., 2004) but
this simple model is consistent withmuch of the data from in vitro
experiments (Palmiter et al., 1999; Baker et al., 2002; Debold et al.,
2008, 2010) and provides the best starting point for understanding
the effects of elevated levels of Pi, H+, and ADP on actomyosin.
In fact, years of investigations using skinned muscle ﬁbers have
led to several hypotheses regarding how elevated levels of Pi, H+
and ADP during fatigue could directly inhibit speciﬁc steps in the
cross-bridge cycle (Cooke, 2007). More recent in vitro approaches
using isolated proteins have attempted to address these hypotheses
FIGURE 1 | A model of the cross-bridge cycle depicting the biochemical
mechanical events. d indicates the powerstroke that causes the
displacement. t on refers to the duration of strong actomyosin strong-binding.
t on is made up of tADP corresponding to the ADP-lifetime and the rigor lifetime
t rigor. Figure is modiﬁed from Debold et al. (2011), reprinted with permission
from the American Physiological Society.
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more directly by taking advantage of the advances in the ﬁeld of
biophysics (Debold et al., 2008, 2011).
EFFECTS OF ACIDOSIS
As far back as 1880 acidosis was known to increase in contract-
ing muscle and was postulated to be directly involved in the loss
of force during periods of stress (Gaskell, 1880). The idea that
the build-up of acidosis was causative in fatigue gained support
from observations that the decrease in muscle performance could
be temporally correlated with a decrease in the intracellular pH
(Dawson et al., 1978). Consistent with this hypothesis early work
on isolatedmuscle suggested that fatiguing levels of acidosis inhibit
force production (Donaldson et al., 1978; Fabiato and Fabiato,
1978; Edman and Lou, 1990; Kentish, 1991; Ricciardi et al., 1994).
However, more recent work in isolated single ﬁbers demonstrates
that the effect of acidosis on force is highly temperature-dependent
(Pate et al., 1995). In fact, at physiological temperaturesmost stud-
ies now indicate that there is little, if any, effect of acidosis on
maximal isometric force (Pate et al., 1995; Knuth et al., 2006).
Some authors have even suggested that acidosis may actually pre-
vent, rather than contribute to, the loss in force during fatigue
(Pedersen et al., 2004), but this remains controversial (Kristensen
et al., 2005). Thus at the very least it appears that acidosis con-
tributes little if at all to the decrease in force during fatigue, at least
at saturating levels of intracellular Ca++ (see Effects of Acidosis
on Muscle Activation).
In contrast to itsminimal effects on force, there is good evidence
from muscle ﬁbers that it may play a role in slowing the velocity
of contraction during fatigue (Knuth et al., 2006; Karatzaferi et al.,
2008). Single ﬁber studies demonstrate that decreasing pH from a
resting value (∼7.0) to a value reached during fatigue (∼6.2) can
slow unloaded shortening velocity by over 30% even near physio-
logical temperatures (30˚C). These ﬁndings suggest acidosis may
have other effects on the actomyosin interaction, speciﬁcally that it
might slow the step in the cross-bridge cycle that limits shortening
velocity. However, since these studies were done in muscle ﬁbers
it is not clear exactly which step in the cross-bridge cycle might be
affected or which of the contractile proteins are helping tomediate
the effect.
Conﬁrmation that acidosis can directly affect the actomyosin
interaction was demonstrated using an in vitro motility assay
(a measure analogous to unload shortening velocity), where the
velocity at which isolated muscle myosin translocates ﬂuores-
cently labeled actin ﬁlaments can be quantiﬁed (Debold et al.,
2008). Increasing acidosis from a resting level (7.4) to fatiguing
levels (6.4), near physiological temperatures (30˚C), in this assay
decreases actin ﬁlament velocity (V actin) by over 65% (Debold
et al., 2008), a ﬁnding qualitatively consistent with observations in
singlemuscle ﬁbers (Knuth et al., 2006). Interestingly, the acidosis-
induced decrease in V actin is greater than that observed in ﬁbers,
suggesting that the structure of the sacromere and/or the pres-
ence of additional contractile proteins present in intact muscle
may attenuate some of the loss in unloaded shortening velocity.
For example, the highly ordered arraignment of the thick ﬁla-
ments in muscle ﬁbers absent in in vitro assays where myosin is
randomly coated on the surface. And there is evidence that the
orientation of myosin to actin affects the single molecule mechan-
ics (Tanaka et al., 1998). Alternatively, the difference in magnitude
may be related to the absence of the regulatory proteins in the
in vitro assays discussed above. Here there is strong evidence for
the involvement of the troponin and tropomyosin in the depres-
sive effects of acidosis (as detailed below) and these proteins may
act to attenuate themagnitude of the acidosis (Fujita and Ishiwata,
1999). It will be important and informative to reconcile this dif-
ference as we attempt to understand the potential role of acidosis
in slowing velocity during fatigue.
In the simplest model (Huxley, 1990), V actin is proportional
to myosin’s unitary step size (d) and the duration of the acto-
myosin strong-binding (t on; i.e., V actin = d/t on). Using this par-
adigm the acidosis-induced decrease in V actin could result from
either a decrease in d and/or an increase in t on. The advent of the
three-bead laser trap assay (Finer et al., 1994) now provides an
unprecedented means of directly determining which single mole-
cule parameter is affected by acidosis (Figure 2). Using this assay
Debold et al. (2008) found that while d was largely unaffected by
acidosis at 30˚C, but that t on was increased by almost threefold at
low pH, which could quantitatively account for the 65% decrease
in V actin that was observed in the in vitro motility assay (Debold
et al., 2008).
As illustrated in Figure 1, t on is composed of two biochemical
states of myosin; the ADP bound state (AM.ADP) and the rigor
state (AM). By manipulating the ATP concentration in the sin-
gle molecule laser trap assay one can further delineate whether
the prolongation of t on results from a slowing of the rate of ADP
release or the rate of ATP-induced dissociation from rigor. The
results of this series of experiments suggested that acidosis has
little effect on the rate of ATP-induced dissociation of actin and
myosin, but increases the duration of theADP-bound state by over
threefold (Debold et al., 2008). The latter effect can fully explain
the acidosis-induced increase in t on and therefore the slowing
of V actin at a fatiguing level acidosis. Thus these ﬁndings pro-
vided some of the ﬁrst direct evidence of the effects of a fatiguing
level of acidosis on a single cross-bridge, suggesting that the effect
can be attributed to a single biochemical transition in myosin’s
cross-bridge cycle.
FIGURE 2 |Three-bead laser trap assay. A schematic representation of
the three-bead laser trap assay showing a single myosin molecule
interacting with a single actin ﬁlament. A quadrant photodiode detector
tracks the motion a trapped bead connected to the actin ﬁlament.
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Now that this information is known what we wish we knew is
the speciﬁc structures and mechanisms responsible for mediating
this effect. Given the knowledge gained from revelation of both the
full amino acid sequence andmyosin’s atomic structure (Rayment
et al., 1993) this task may now be a less daunting one. An inter-
esting starting point to identify the important structures would be
to take advantage of the differential sensitivity to acidosis of fast
type II and slow type I muscle ﬁbers (Metzger and Moss, 1990).
Fibers expressing the fast type II, IIx, or IIb myosin heavy chain
(MHC) seem to be more sensitive to a decrease in acidosis than
ﬁbers with slow type I MHC. A Comparison of all the different
residues of each protein might be inefﬁcient, however since veloc-
ity is strongly governed by the rate of ADP-release (Siemankowski
et al., 1985) the structures affecting this rate present an attractive
area to target in myosin’s heavy chain. The sequences for type I
and each type II isoform (IIa, IIx, and IIb) are highly homolo-
gous except for the surface binding loops (Chikuni et al., 2004).
And there is evidence that these binding loops can inﬂuence the
overall ATPase rate, shortening velocity, and the ADP-release rate
(Kurzawa-Goertz et al., 1998) therefore this may be a key area to
probe the differential sensitivity to acidosis.
EFFECTS OF ACIDOSIS ON MUSCLE ACTIVATION
In addition to direct effects on the actomyosin cross-bridge cycle,
acidosis is also thought to indirectly affect the actomyosin inter-
action by altering the Ca++ sensitivity of muscle. A decreased
Ca++-sensitivity means that less force will be produced at the
same level of activation, thus unlike the reduced effect of aci-
dosis observed at saturating Ca++ levels (Pate et al., 1995) if
acidosis disrupts muscle activation force will be compromised at
sub-saturating Ca++ levels. This may play a particularly impor-
tant role during the latter stages of fatigue, when the intracellular
[Ca++] is thought to compromised, due to decreased release from
the sarcoplasmic reticulum (Lee et al., 1991).
Muscle activation starts when a complex series of molecular
motions following the binding of Ca++ to TnC ultimately lead
to the movement of tropomyosin away from a position where it
blocks the myosin-binding sites on actin. Improvements in bio-
physical techniques combined with new high resolution structures
of the contractile proteins have revealed new details of this process
(Galinska-Rakoczy et al., 2008). These ﬁndings are leading tomore
sophisticated hypotheses about how contraction is regulated at
the molecular level and will be crucial to understanding how this
process might be disrupted during fatigue. Much of these new
data support a model that posits that Tm oscillates between three
distinct positions on actin (McKillop and Geeves, 1993); the ﬁrst
being a “Blocked-state” where the myosin binding sites on actin
are completely unavailable; a second,“Closed-state”whereTmonly
reveals the weak binding sites on actin; and a third,“Open-state” in
which the sites for strongmyosin-binding are available andmyosin
can therefore generate force and motion (Gordon et al., 2000). In
this model the binding of Ca++ to TnC increases occupancy of
the Closed-state, but only after myosin strongly binds to actin in
the Open-state is the ﬁlament fully activated. Thus full activation
of the thin ﬁlament requires both Ca++ dependent process and
myosin being strongly bound to actin. We also know that this
process is highly cooperative, meaning that the binding of one
myosin increases the probability that neighboring myosin mole-
cules will bind to actin. And there is evidence that the putative
agents of fatigue might affect this cooperative behavior (Debold
et al., 2006),whichwould likely show the greatest alterations under
conditions where Ca++ release is compromised.
Support for the above model of activation and its cooperative
properties have been provided from structural evidence showing
that Tm can exist in three distinct positions on actin (Galinska-
Rakoczy et al., 2008). In addition, recent single molecule laser
trap experiments using actin ﬁlaments reconstituted with TnTm
demonstrate that in the absence of Ca++ TnTmdecrease the prob-
ability of myosin strong-binding by 100-fold, but that the binding
of one myosin increases the probability of a neighboring myosin
binding by more than 10-fold (Kad et al., 2005). The later result
is consistent both with this “three-state model” of thin ﬁlament
activation and nicely demonstrates the cooperative aspect at the
single molecule level. This later technique could provide interest-
ing insight into how acidosis might exerts its effects on during
fatigue.
In addition to these studies which highlight the recent work
characterizing Tm dynamics, the revelation of the crystal struc-
ture of the core domain of Tn has provided exciting details of
the intra-molecular dynamics of Tn resulting fromCa++-binding
to TnC (Takeda et al., 2003), and the movements that might ulti-
mately couple to the positions of Tmon actin. Themost signiﬁcant
ﬁnding from these structural investigations suggests that in the
absence of Ca++ actin and myosin are prevented from interacting
because the C-terminal portion of the inhibitory subunit of Tn
(TnI) is tightly bound to actin. This constrains Tm in a position
that blocks the myosin binding sites on actin. Binding of Ca++
to TnC opens up a hydrophobic patch the N-terminal lobe TnC
that has an afﬁnity for a speciﬁc helix in the C-terminal portion
of TnI causing it to dissociate from actin and bind to N-terminal
lobe of TnC. This dissociation of TnI from actin frees Tm to move
out of way of the myosin binding sites on actin, allowing actin,
and myosin to bind. These new molecular insights are providing
unprecedented detail of the molecular basis of muscle activation
and will therefore help us to pinpoint where activation process
acidosis might exert its depressive effects.
Early work, using skinned single muscle ﬁbers, established that
acidosis decreases Ca++ sensitivity (Fabiato and Fabiato, 1978)
andmore recent evidence indicates this effect can be recapitulated
in the in vitro motility assay where acidosis can slow the V actin of
actin ﬁlaments reconstituted with TnTm (Sata et al., 1995;VanBu-
ren et al., 2002). To better understand the molecular basis of this
effect and isolate the speciﬁc structures involved researchers have
used advances in molecular biology and biophysical techniques to
bothmanipulate the structural of the regulatory proteins and then
directly assess the impact on function in vitro.
The interest in identifying the structural elements responsible
for the acidosis-induced decrease in Ca++-sensitivity originally
stemmed from an interest in understanding the effects of acute
ischemia on cardiac function (Blanchard and Solaro, 1984; Solaro
et al., 1988), a condition that shares with fatigue the rapid accumu-
lation of metabolites. It was readily apparent that cardiac muscle
was much more strongly affected by acidosis than skeletal mus-
cle, particularly at sub-maximal levels of activation. In fact after
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cardiac muscle, fast skeletal muscle is the next most sensitive
followed by slow skeletal, which shows the smallest decrease in
Ca++-sensitivity under acidic conditions (Morimoto et al., 1999).
The structural differences between skeletal isoforms may provide
avenues to pinpoint the key structures and molecular motions
which gives rise to these effects. Fortuitously, researchers have
focused heavily on understanding the effects acidosis, often using
pH levels experienced during fatigue (Fabiato and Fabiato, 1978;
Solaro et al., 1988; Ball et al., 1994). Thus the ﬁndings provide
important insight into the role of acidosis in the fatigue process
as well.
Some of the initial work suggested that the differential sensi-
tivity between cardiac and skeletal muscle might be attributable to
the subtle structural differences in the isoforms of troponin (Blan-
chard and Solaro, 1984). A subsequent comparison of neonatal
cardiac muscle, which expresses a slow skeletal isoform of TnI
(ssTnI) with adult cardiac muscle, which expresses cTnI, revealed
that the neonatal isoform of TnI was much less sensitive to aci-
dosis (Solaro et al., 1988). This suggested that the differential
responsemight be attributed to the speciﬁc regions in TnI that dif-
fer between ssTnI and cTnI. However, it is important to point out
that in this experiment the isoforms of TnC and the tropomyosin
binding subunit of TnT were also slightly different, preventing the
authors from attributing the effect exclusively to TnI. To attempt
to resolve this issue Ball et al. (1994) extracted Tn from fast skeletal
muscle ﬁbers (fsTn) and replaced the fsTnI with the cardiac iso-
form of TnI isoform and then incorporated the full Tn complex
back into the skeletal muscle ﬁbers. These manipulated skele-
tal ﬁbers displayed the mild acidosis sensitivity characteristic of
skeletal muscle ﬁbers despite containing cardiac TnI, suggesting
that TnI alone does not govern the differential response to acido-
sis. In a subsequent set of experiments both the fsTnI and fsTnC
were replaced with cTnI and cTnC and under these conditions the
ﬁbers demonstrated this increased sensitivity to acidosis charac-
teristic of cardiac muscle. This led the authors to conclude that
the interaction between TnC and TnI is crucial for mediating
the acidosis-induced depression in Ca++-sensitivity. This ﬁnd-
ing may not be surprising in light of the recent structural evidence
that the interaction of these two subunits is crucial for activa-
tion (Takeda et al., 2003) but clearly more precise manipulation of
the structures was required to understand this more effect more
fully.
Based on the above evidence researchers have focused on
indentifying the crucial structural regions within the TnI sub-
unit that might be responsible for the differential response of
cardiac and skeletal muscle. Initial experiments in this process
used chimeras of ssTnI and cTnI and measured the effect on
the force-pCa relationship (Day et al., 2007). By systematically
reducing the number of amino acids that differed between the
cardiac and skeletal isoforms researchers were able to assign a
good portion of the differential sensitivity to acidosis to the
carboxy-terminus region of TnI. In fact the same research group
used point mutations to suggest that the differential response
to acidosis was largely attributable to a difference of one amino
acid at residue 164 (Day et al., 2006). In an elegant follow-
up study they directly tested this hypothesis by substituting the
alanine at residue 164 in cTnI for the histadine, present in
ssTnI, made the cardiac muscle respond nearly identical to slow
skeletal muscle, essentially protecting it against the depressive
effects of acidosis (Day et al., 2006). The authors postulated
that the since pKa of histadine is in the physiological range,
its presence makes ssTnI better able to buffer the free pro-
tons and therefore maintain its Ca++-sensitivity under acidic
conditions (Westfall and Metzger, 2007). This of course has
important potential applications for the treatment of myocar-
dial ischemia but also highlights nicely how functional biophysical
assays paired with molecular biology provide exceptional insight
into themolecular basis of the depressive effects of acidosis during
fatigue.
Based on these experiments it is clear that the depressive effects
of acidosis involve TnI, particularly in cardiac muscle, however
there is also evidence that the other subunits of Tnmay be involved
in this decreased Ca++-sensitivity, particularly in skeletal muscle.
In an effort to delineate a possible role for TnC in the acidosis-
induced depression of Ca++-sensitivity, Metzger et al. (1993)
replaced the TnC in skeletal muscle ﬁbers (sTnC) with the cardiac
isoform (cTnC) and found that this increased the sensitivity of
the skeletal ﬁbers to acidosis suggesting it may be more important
to fatigue than TnI (Metzger et al., 1993). Based on this evidence
and ﬁndings that indicate that acidosis directly reduces the afﬁnity
of Ca++ binding sites on TnC (Parsons et al., 1997) authors have
suggested that high levels of H+ may temporally alter the struc-
ture of the Ca++ binding sites on TnC. In addition, the C-terminal
region of TnC makes important contacts with TnI during activa-
tion (Takeda et al., 2003) and this could help explain why both TnI
and TnC are implicated in mediating this depressive effect of aci-
dosis (Ball et al., 1994). Since the effects of acidosis on TnC’s Ca++
binding afﬁnity are signiﬁcant in both cardiac and fast skeletal iso-
forms,but the effectsmediated throughTnI aremoreprominent in
cardiacmuscle, this suggests that the effectsmediated throughTnC
may be more important for skeletal muscle fatigue. The greater
potential involvement of TnC in the fatigue process could stem
from the fact that the fsTnC has two low-afﬁnity Ca++-binding
sites while cTnC has just one (Gordon et al., 2000), although this
is an idea that needs further exploration.
There is also evidence that Tm-binding subunit of Tn (TnT)
is involved in the acidosis-induced decrease in Ca++ sensitivity
in skeletal muscle (Ogut et al., 1999). In support of this notion
Nosek et al. (2004) demonstrated in mice, genetically engineered
to express the fast skeletal isoform of TnT in themyocardium, that
there was an increased sensitivity to acidosis compared to those
with the normal those with the normal cTnT. This is particu-
larly interesting for skeletal muscle fatigue because it suggests that
while fsTnI may attenuate the Ca++-sensitivity, fsTnT may actu-
ally accentuate the decrease in Ca++-sensitivity in skeletal muscle.
This would imply a greater role for TnT than TnI in skeletal mus-
cle fatigue. Since the structural differences between the cardiac
and skeletal isoforms of TnT are now well known the authors
concluded that the subtle charge differences in the NH-terminal
domain between cardiac and fast skeletal may account for the dif-
ferential response to acidosis (Nosek et al., 2004). Here a systemic
approach, similar to the one for taken for TnI, could be employed
to identify the structures and mechanisms responsible TnT’s role
in the acidosis-sensitivity of skeletal muscle.
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These investigations into the structure and function of Tn
have been very important for understanding how the loss of
contractility during ischemic heart disease and provide an impor-
tant starting point for understanding the role in of acidosis in
the decreased Ca++-sensitivity during fatigue. Interestingly, while
much of the effect in cardiac muscle can be localized to a speciﬁc
region in TnI the evidence from skeletal muscle suggests a greater
involvement of TnC and TnT. Future work in which systematic
series of structural perturbations of each Tn subunit and Tm are
paired with functional assessments in an in vitro setting will more
clearly delineate the role that the regulatory proteins play in the
acidosis-induced decrease in Ca++-sensitivity.
EFFECTS OF Pi
One of the strongest correlates with the loss of force during fatigue
is the accumulation of Pi in muscle, as demonstrated in NMR
studies using in vivo muscle (Dawson et al., 1978). The associ-
ated decrease in force is believed to be due to a direct effect in
the contractile proteins since in non-fatigued muscle ﬁbers it is
routinely observed that high levels of Pi reduce maximal isomet-
ric force (Cooke and Pate, 1985; Hibberd et al., 1985; Nosek et al.,
1987; Cooke et al., 1988; Pate and Cooke, 1989; Debold et al., 2004,
2006).
Muscular force, at the molecular level, is dependent on the
product of the unitary force of a single cross-bridge (Funi) and
the duty cycle (the percentage of the ATPase cycle spent strongly
bound to actin; VanBuren et al., 1995). Therefore Pi could affect
either one or both of these parameters to cause a reduction in
force. The prevailing model suggests that the duty cycle is reduced
because the rebinding of Pi rapidly reverses the lever arm rotation
and leads to detachment of myosin from actin reducing the num-
ber of strongly bound cross-bridges (Takagi et al., 2004). Strong
support for this model comes from the observation that elevated
levels of Pi reduce maximal isometric force in skinned muscle
ﬁbers in a concentration-dependent manner (Pate and Cooke,
1989). Furthermore,elevatingPi in a singlemolecule assay suggests
that Pi release and myosin’s lever arm rotation are closely coupled
(Baker et al., 2002). Therefore the presence of high levels of Pi
would act to decrease myosin’s duty cycle with little or no effect on
Funi. However, this mechanism of force production still remains
controversial because isolated muscle preparations that incorpo-
rate spin-labeled probes to sensitive to myosin’s lever arm rotation
do not detect a reverse shift the distribution of myosin heads from
the post-powerstroke to pre-powerstroke state following exposure
to high levels of Pi. This ﬁnding suggests that rather than revers-
ing lever arm rotation and inducing detachment elevated Pi may
decrease the force per cross-bridge (Baker et al., 1999). Findings
such as this have led to the proposal of thermodynamic models of
muscular contraction (Baker et al., 1999; Karatzaferi et al., 2004)
as opposed to the more conventional molecular models (Huxley,
1957). In support of these types of models maximal isometric
force is linearly decreases with the logarithm of the [Pi] (Pate
and Cooke, 1989). This suggests that elevated levels of Pi during
fatigue decrease force by decreasing the available energy from the
hydrolysis of ATP.
In addition, to the thermodynamic information we are also
gaining important atomic level insight into the internal motions
of myosin that involve Pi. In fact, the effects of Pi on the cross-
bridge cycle are important to understanding the molecular basis
of contraction because the release of Pi from myosin is believed
to be the step most closely associated to the rotation of myosin’s
lever arm, the key molecular event underlying the generation of
force and motion (Holmes and Geeves, 2000). In a conventional
molecular model of the cross-bridge cycle Pi is thought to reduce
force by rebinding to myosin in the AM.ADP state and rapidly,
causing both reversal of myosin’s lever arm rotation and the disso-
ciation fromactin (Takagi et al., 2004). In isometrically contracting
muscle this molecular process would lead to a decrease in the
number of strongly bound cross-bridges and therefore force. In
the 1980s this may have provided a complete mechanistic expla-
nation for the effect of Pi on force, however advances in structural
biology leading to the revelation of the 3-D atomic structure of
myosin (Rayment et al., 1993; Figure 3) means that we can now
gather much more detail about how this process might occur.
For example, what internal molecular motions within myosin’s
active site lead to the Pi-induced reversal of the lever arm rotation
that ultimately lead to the reversal of the lever arm rotation and
detachment from actin? Atomic resolution structures of myosin
in different nucleotide states have provided important clues into
these motions, at least from the perspective of Pi-release and lever
are rotation(Holmes and Geeves, 2000). In fact, with all this new
structural information, the suggestion that Pi reduces force during
fatigue by simply reversing force generating step is analogous to
suggesting that a clock tells time by the moving its hands. In the
case of the clock you would be ignoring the intricate motions of
gears and springs behind the face of the clock that precisely govern
the rotation of the hands. Similarly, we now know that the reversal
of force-generating step by myosin likely involves the coordinated
movement of several regions within the myosin molecule.
FIGURE 3 | Atomic structure of a myosin molecule A ribbon
representation of the head portion myosin (S1).The heavy chain is
colored in blue, gray, green, and red, denoting different regions of the
protein. The light chains are colored in yellow (Essential) and pink
(Regulatory). The upper portion of the motor domain is separated by a large
cleft (actin-binding cleft), the opening and closing of which modulates actin
afﬁnity. Subtle changes in the nucleotide-binding site are ampliﬁed in the
converter region resulting in a large rotation of the lever arm. Figure from
Geeves and Holmes (2005), reprinted with permission from the publisher.
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In recent years systematic and careful experimental designs
have providing important insights into the basic intra-molecular
motions deep within myosin that link subtle changes in the ATP
binding site to large conformational changes in the converter
region and lever arm that are associated with force generation
(Holmes and Geeves, 2000). Since myosin is quite a large pro-
tein, there must be pathways of communication that allow distant
regions of the protein coordinate the biochemical and structural
to ensure energy is not wasted. Most importantly, strong-binding
of myosin to actin must be precisely timed and coordinated with
rotation of the lever arm to effectively displace an actin ﬁlament
and/or generate force. Both of these events are also coupled to
the release of Pi from myosin’s active site, this mechanochemical
coupling is thought to ensure efﬁcient use of the energy from the
hydrolysis of ATP (Holmes and Geeves, 2000). Coordination of
these events is believed to be initiated through the opening and
closing of a large cleft in the motor domain, involving a strut that
spans the cleft (Figure 3). This large cleft, which reaches from the
actin-binding domain deep into active site, closes upon strong-
binding to actin, a movement coupled to subtle rearrangements
within the nucleotide binding pocket and to the release of Pi.
Through a series of linkages and switches these subtle motions in
the active site are communicated and ampliﬁed by the converter
domain to cause the lever arm to rotate and generate the∼10 nm
displacement of an actin ﬁlament (Holmes, 2005). The events of
rebinding are not yet known in the same intricate detail, but it is
generally assumed that the reaction is reversible and the rebinding
of Pi during fatigue reverses this sequence of events to reduce force.
Thus these basic ﬁndings have the potential to provide unprece-
dented molecular detail of the fatigue within muscle’s molecular
motor and it will be interesting to follow the developments as the
number of structures and the resolution increases.
It is clear these and similar structural data are providing impor-
tant insights into the molecular basis of muscle contraction and
indirectly insight into the process of fatigue, however it is impor-
tant to point out that structures are only “snapshots in time.”
Therefore they do not provide a full characterization of all the
motions within the protein through time.What we wish we knew,
and could see directly, is how Pi rebinds to the active site of myosin
and how this event is linked to conformational changes in the
actin-binding site, converter, and lever-arm in real-time. Given the
time scales of these events this will be difﬁcult but recent devel-
opments in molecular dynamics simulations may soon provide
important insights into these events in the near future (Cecchini
et al., 2010).
Despite extensive work on the effects of Pi on force and the
wealth of knowledge of structural states there are still effects of
Pi on contractile function that are not easily explained with exist-
ing models. For example, the effects of Pi on shortening velocity
are much more equivocal, and seemingly more complex, than the
effects on force. In skinned single muscle ﬁbers high levels of
Pi most often have little effect on unloaded shortening velocity
(Cooke et al., 1988), however altering the conditions slightly can
cause Pi to elicit a decrease (Pate andCooke, 1989) or even aminor
increase in velocity (Pate and Cooke, 1989). Similar observations
have been made in in vitro motility experiments where Pi can
either increase or decrease V actin depending on the experimental
conditions (Debold et al., 2011). In both preparations the effects
of Pi are highly dependent on the ATP concentration, at high ATP
Pi can cause a slight increases in V actin (Homsher et al., 1992)
while at μMATP levels it slowsV actin (Warshaw et al., 1991). This
issue has recently been re-examined and the data suggest that the
opposing effects result from the ability of Pi to rebind to the either
AM.ADP or rigor states (see Figure 1) of myosin (Debold et al.,
2011). In this variation of the simple detachment-limited model
(Figure 1), Pi rebinding to the AM.ADP state facilitates dissocia-
tion from a post-powerstroke state and therefore limits duration
of strong-actin binding and increases velocity by ∼5%. However
the lifetime of the AM.ADP state is very short in skeletal muscle
myosin and the afﬁnity rather low so this sequence is not read-
ily observed under normal conditions. By contrast the when Pi
rebinds to the rigor state it prevents ATP from binding, prolong-
ing the strongly bound state (i.e., t on) and therefore slows velocity.
Simulations governed by this mechanism were able to accurately
capture both the Pi-induced increase in velocity at ATP and the
depression in velocity at lowATP (Debold et al., 2011). These ﬁnd-
ings were then extended tomore fully understand the effect during
fatigue-like conditions by manipulating the pH as well as the Pi
levels (Debold et al., 2011). In this experiment it was demonstrated
that the Pi-induced increase inV actin was signiﬁcantly enhanced at
low pH. For example, at pH 6.5, the addition of 30mM Pi caused
V actin to almost double (Figure 4). The effect was still signiﬁcant
but smaller in magnitude in a less acidic pH of 6.8 and recently
FIGURE 4 |The effect of Pi at low pH onV actin. In vitro motility actin
ﬁlament velocities from chicken skeletal myosin and actin under various
levels of pH and Pi. Values represent mean±SEM for V actin at each pH and
Pi level. Data were analyzed using a two-way ANOVA, * indicates
signiﬁcantly (p<0.05) different from 0mM Pi and # indicates a signiﬁcant
interaction, meaning that the increase in V actin in response to Pi was greater
at both pH 6.8 and 6.5 than at 7.4. Figure from Debold et al. (2011),
reprinted with permission from the American Physiological Society.
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a similar effect was reported under even more severe fatigue-like
conditions (Greenberg et al., 2010). Taken together these ﬁndings
strongly suggest the effects of Pi on velocity are dependent on the
pH. Debold et al. (2011) interpreted the ﬁndings using the same
modiﬁed simple model described above. The simulations using
the model suggested that the changes in t on were due to either
acidosis prolonging the AM.ADP state or by Pi shortening the life-
time of the AM.ADP state. Since our earlier work demonstrated
that pHprolongs theAM.ADP state this suggests that there ismore
time for Pi to rebind to actomyosin, making the increase in V actin
more pronounced at low pH, providing a kinetic basis for the pH
dependence of the effect (Debold et al., 2011).
These ﬁndings have relevance to fatigue because they suggest
that the depressive effects of acidosis onV actin may be offset by the
effects of Pi. However, since pH also slows myosin’s overall ATPase
rate (Stone and Prevost, 1973) these ions would likely act addi-
tively to reduce force in muscle and thus power. This hypothesis
is supported by the observation that in a loaded in vitro motil-
ity assay a fatigue-like milieu (pH 6.2, 30mM Pi, 0.3mM ADP)
reduced myosin’s force generating capacity at a given velocity and
translated into profound reduction in the peak power generating
capacity of myosin (Figure 5). Therefore a Pi-induced increase in
shortening velocity may come at the expense of force generation
and ultimately power at themolecular level. Here wewishwe knew
how these ionic changes might affect force and power in vitro and
with recent advances in the laser trap assay (Debold et al., 2005)
this is something that could be answered in the near future.
EFFECTS OF Pi ON MUSCLE ACTIVATION
The effects of fatiguing levels of Pi, like acidosis, typically decrease
the Ca++-sensitivity of force in single muscle ﬁbers (Millar and
Homsher, 1990, 1992; Walker et al., 1992; Palmer and Kentish,
1994; Metzger, 1996). Furthermore, recent work suggests that
this effect this is more pronounced near physiological tempera-
tures vs lower temperatures (Debold et al., 2006; Figure 6). This
effect may be particularly relevant for fatigue because it means
that during the later stages of fatigue, when intracellular Ca++
is reduced (Westerblad et al., 1991), increases in Pi would have
a more dramatic depressive effect on isometric force. Despite
being a well-established phenomenon, the molecular mechanisms
underlying this Pi-induced depression of Ca++-sensitivity effect
remain poorly understood.
In contrast to the putative effects of acidosis on muscle activa-
tion,most evidence indicates that Pi does not disrupt the function
of Tn, including Ca++ binding to TnC (Palmer and Kentish,
1994). This suggests that the effect is mediated through a dis-
tinctly different mechanism than the acidosis-induced depression
in Ca++-sensitivity (Fabiato and Fabiato, 1978). Rather most evi-
dence suggests that Pi’s strong depressive effect on the force–pCa
relationship is likely mediated through Pi’s effect on a strongly
bound actomyosin cross-bridge (Millar andHomsher, 1990, 1992;
Walker et al., 1992; Palmer and Kentish, 1994; Metzger, 1996;
Debold et al., 2006). Strong-binding of myosin to actin is required
for full activation of the thin ﬁlament (McKillop and Geeves,
1993) therefore at high concentrations, Pi rebinding to myosin
is thought to cause the reversal of the force generating step (Takagi
et al., 2004). This is believed to have several effects on the level of
thin ﬁlament activation; ﬁrst the stabilization of Tm in the Open
state (i.e., full activation) requires myosin strong binding (Gor-
don et al., 2000) thus this effect would be reversed by elevated
Pi. Secondly, strong-binding also contributes to the cooperative
binding of myosin through propagation of the motions of Tm
on actin (Gordon et al., 2000) from one regulatory unit (7Actin
monomers, 1Tn, 1Tm) to its nearest neighbors, here a Pi-induced
decrease in strong-binding would be expected to reduce this effect
and thus activation. Another source of cooperative activation that
is also dependent on strong-binding is the force-induced increase
in TnC’s afﬁnity for Ca++ (Gordon et al., 2000), an increase in Pi
would reduce this effect, leading to a muscle that is less sensitive
to Ca++ all of these contributing to a reduced sensitivity to Ca++
in a force–pCa relationship.
While the above ﬁndings provide plausible mechanisms for the
rightward shift in the force–pCa relationship there are some ﬁnd-
ings that suggest our understanding is incomplete. For example,
elevated levels of Pi can increase the steepness of the force–
pCa curve suggesting an increase rather than a decrease in
FIGURE 5 | In vitro force–velocity (A) and force–power (B) relationships.
Fatigue was simulated by exposing the myosin pH 6.2, 30mM Pi and 0.3mM
ADP and the effects on skeletal muscle myosin’s force–velocity relationship
determined. Load was applied by adding increasing amounts of an
actin-binding protein (alpha-actinin). Data were ﬁt with the Hill force–velocity
equation (Hill, 1938) with the black line normal conditions and the gray line
fatigue-like conditions. The force–power relationships (B) were derived by
calculating the product of force and velocity and ﬁt to the Hill force–power
equation (Hill, 1938). Figure reprinted from Greenberg and Moore (2010) with
permission from JohnWiley and Sons.
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FIGURE 6 | Effect of Pi on the force–pCa relationship. Skinned single
ﬁber muscle forces measured at increasing concentrations of free
Ca++ (displayed in pCa, −log units) in the presence and absence of
30mM Pi (A). The forces are normalized to the maximum reached at
saturating pCa (4.5) and ﬁt with the Hill plot (B). The leftward shift in the
curve indicates that elevated Pi makes the ﬁbers less sensitive to Ca++.
Figure is modiﬁed from Debold et al. (2006), reprinted with permission
from the American Physiological Society.
cooperativity, even in the face of decreasing Ca++-sensitivity as
evidenced by a decrease in the pCa50 (Millar andHomsher, 1990).
The increased cooperativity seems inconsistent with the mecha-
nism outlined above and suggests that a cross-bridge to which Pi
rebinds behaves differently than amyosinmolecule in a state prior
to Pi-release. In addition, the effects of the velocity–pCa relation-
ship have been equivocal with the earliest work demonstrating that
Pi decreases Ca++sensitivity of V actin (Sata et al., 1995), yet more
recent work suggests that elevated Pi seems to have little if any
impact on the velocity–pCa relationship (Gorga et al., 2003). This
resolution of these issues will be crucial to understanding how
this important ion mediates its potent effects on fatigue. Here it
might be informative to directly observe the effects on Pi on the
behavior of a single actomyosin cross-bridge by using a regulated
thin ﬁlament in the laser trap assay (Kad et al., 2005) both under
unloaded and loaded conditions.
EFFECTS OF ADP
At rest, ADP is typically maintained quite low (∼10μM) inside
the cell due to the creatine kinase reaction strongly favoring the
formation of ATP. However, with intense contractile activity the
concentration of creatine phosphate rapidly decreases and creatine
reciprocally increases. These changes shift the equilibrium of the
reaction so that when creatine phosphate is completely depleted
intracellular levels of ADP can be as high as 1mM (Nagesser et al.,
1993). However others have argued that this might signiﬁcantly
overestimate the values reached during fatigue in in vivo muscle
(Cooke, 2007). This controversy aside it is clear that even 0.5mM
ADP can signiﬁcantly affect both the force and velocity generating
capacity of myosin in vitro (Greenberg et al., 2010).
Observations from skinned single muscle ﬁbers consistently
reveal that mM levels of ADP slow unloaded shortening velocity
(Cooke and Pate, 1985; Metzger, 1996). ADP has a similar effect
on V actin measured in a motility assay, suggesting that ADP slows
velocity by directly inhibiting myosin function (Greenberg et al.,
2010). In contrast high levels of ADP have the opposite effect
on ﬁber force, consistently causing small but signiﬁcant increases
maximal isometric force (Cooke and Pate, 1985; Hoar et al., 1987;
Metzger, 1996; Fukuda et al., 2000).
The opposing effects on force and velocity can be explained
at the molecular level by assuming that ADP competes with ATP
for binding to myosin’s active site. In a simple detachment model
(Figure 1),when levels are highADP can readily rebind tomyosin’s
empty nucleotide-binding site in the rigor state resulting in the
reformation of the AM.ADP state. This state is a strongly bound
post-powerstroke state, therefore high ADP acts to prolong t on,
while having no effect on d, and therefore slows velocity (according
to V= d/t on). This molecular concept is supported by observa-
tions from the single molecule laser trap assay where mM ADP
levels have been shown to prolong the strongly bound lifetime of
a single actomyosin bond without affecting d (Baker et al., 2002).
Prolongation of t on,while slowing velocity,would also increase the
number of strongly bound cross-bridges at any given moment.
Therefore, since force is directly dependent on the number of
attached cross-bridges this would act to increase maximal isomet-
ric force in muscle. These data and accompanying interpretations
provide a simple, molecular level explanation for the slowing of
velocity but increased force observed with increasing ADP levels.
While these data provide important information,maximal iso-
metric force and unloaded shortening velocity only represent two
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endpoints on the force–velocity relationship continuum. There-
fore to fully understand if ADP contributes to the loss of muscular
power during fatigue it may be more informative to characterize
its effects on myosin’s load-dependent velocity. This was recently
accomplished using a modiﬁed motility assay where myosin
worked against the load of an actin-binding protein (Greenberg
et al., 2010). The results revealed that elevated levels of ADPattenu-
ated load-induced decrease inV actin that characterizes muscle and
myosin. This implies that elevatedADP levels may have little effect
onmyosin’s power-generating capacity and thus might play only a
small or even protective role in in vivo fatigue. Here, examining the
effect of ADP the load dependence of a single actomyosin interac-
tion, a technique recently used to characterize the load dependence
of smooth muscle muscle (Veigel et al., 2003). These are related
techniques may provide even more crucial insight into both the
mechanism of fatigue and the role of ADP-release in contraction.
EFFECTS OF ADP ON Ca++-SENSITIVITY
As detailed in the previous section the potential role of ADP in
fatigue has been strongly questioned due to the debate over the
concentrations achieved during high intensity exercise (Cooke,
2007). However the highest estimates suggest the ADP can reach
1mM and this level of ADP can have a signiﬁcant impact on the
Ca++-sensitivity both in muscle ﬁbers and in vitro (Greenberg
et al., 2010). In skinned single muscle ﬁbers elevated levels of ADP
slow unloaded shortening velocity but enhance maximal isomet-
ric force and it also increases the sensitivity to Ca++ evidenced by
a leftward-shift in the force–pCa relationship (Hoar et al., 1987).
Thismight seembeneﬁcial during fatigue since it could potentially
offset a loss in force caused by other metabolites, however ADP
has the opposite effect on contraction velocity, slowing unloaded
shortening velocity at both maximal and submaximal Ca++ con-
centrations (Metzger, 1996). Thus the ADP-induced slowing of
velocity might offset an increase in force and as a result powermay
ultimately be compromised.
The ADP-induced slowing of V actin is thought to be medi-
ated by a direct effect on myosin since the observations from
the in vitro motility assay using reconstituted thin ﬁlaments
(actin+Tn+Tm) also show ADP slows actin ﬁlament velocity
(Gorga et al., 2003). In these in vitro investigations, ADP levels
of only 0.5mM can signiﬁcantly decreases V actin at both maxi-
mal and submaximal Ca++ levels, and this effect is concentration
dependent with 5mM ADP causing V actin to decrease by ∼80%
at maximal Ca++ (Gorga et al., 2003; Figure 7).
In the model of the cross-bridge cycle, described above
(Figure 1), elevated ADP is thought to rebind to myosin in the
rigor state, pushing the cross-bridge back into the AM.ADP state.
This scenario presumably prolongs the duration of the strongly
bound state causing velocity to slow, but it would increase activa-
tion of the thin ﬁlament via strong-binding activation. This model
nicely accounts for the increase in force and Ca++-sensitivity via
an increased number of strongly bound cross-bridges and also
the decrease in velocity due to the same increase in t on. Therefore
while the increase in force due to elevatedADPmight attenuate the
effects of other metabolites (Hoar et al., 1987), any beneﬁt tomus-
cle performance would be offset by the much more pronounced
decrease in velocity (Gorga et al., 2003). Thus this evidence implies
FIGURE 7 | Effect of ADP on the velocity–pCa relationship in vitro.
Regulated actin ﬁlament velocities plotted as a function of increasing ADP
concentrations. The ADP levels were increased from 0.5mM ADP (squares,
dotted line), to 2mM (triangles up, dashed regression), and 5mM (triangles
down, dash-dot regression) and compared to control experiments with no
added ADP (circles, solid regression). Elevated ADP signiﬁcantly decreased
maximal velocity but increased the pCa50 of the thin ﬁlament in a
concentration-dependent manner. Figure modiﬁed from Gorga et al., 2003,
reprinted with permission from Cell Press.
a small but potentially signiﬁcant role for elevated levels of ADP
in fatigue.
EFFECTS OF REACTIVE OXYGEN SPECIES AND OTHER STRUCTURAL
CHANGES
Reactive oxygen species (ROS) and nitric oxide (NO) are some-
what newer putative agents of fatigue, but an accumulating body
of literature is beginning to indicate that they may play a sig-
niﬁcant role in the loss of muscular force and velocity during
fatigue (Smith and Reid, 2006). ROS are oxygen containing mol-
ecules, such as superoxide (O2−), that have unpaired electrons
making them highly reactive and thus capable of damaging mem-
branes and structurally modifying various contractile proteins.
The potential structural modiﬁcations include the formation of
disulﬁde bridges between neighboring cysteine residues as well as
modiﬁcations of methionine residues. Many species of ROS and
NO have now been demonstrated to accumulate inside contract-
ing muscle cells during intense activity. In addition, there is also
evidence that they may be playing a causative role in the fatigue
process (Smith and Reid, 2006). However, the effects are concen-
tration dependent in a complex manner. When levels of ROS are
low, as might occur at rest or even in the early stages of fatigue,
they appear to enhance force production in isolated muscle (Reid
et al., 1993). In contrast, at higher concentrations (as might occur
in the later stages of fatigue) certain species, such as H2O2, begin
to inhibit contractile function (Andrade et al., 1998). Thus while
small amounts of ROS may actually improve contractile function,
the negative impact of higher concentrations suggests they can still
play a causative role in the fatigue process.
Several groups are now beginning to explore the molecular
basis of the effects of ROS and NO species on contractile function
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in vitro. Snook et al. (2008), recently set out to the probe the
molecular basis of the effects of the ROS peroxynitrite (ONOO−)
using an in vitro motility assay, exposing both myosin and actin
to increasing concentrations of ONOO− andmeasuring its effects
myosin’s ability to move actin and generate force. At concentra-
tions greater than 10μM, ONOO− caused signiﬁcant reductions
inV actin, suggesting that this species and concentration negatively
can negatively affect actomyosin function. They complemented
these functional assessments with biochemical experiments to
determine the nature of these structural changes, and found that
ONOO− caused an increase in tyrosine nitration of both actin and
myosin, with myosin showing the strongest relationship between
tyrosine nitration and the decrease in V actin (Snook et al., 2008).
Interestingly, exposing myosin to the same level of ONOO− actu-
ally increased its force-generating capacity, an observation that
agrees with ﬁndings from intact muscle and skinned ﬁbers (Allen
et al., 2008). This suggests that this species might attenuate the loss
of force during fatigue. It is interesting that the opposite effects on
velocity and force are similar to the effects of ADP on myosin,
suggesting that ONOO− may slow the same step in the cross-
bridge cycle, ADP-release. In terms of fatigue, however, this makes
interpretation of the role of ONOO− in the fatigue process more
difﬁcult because it has opposite effects on force and velocity. The
implications for its role in the fatigue process may depend on the
relative magnitude of the effect force vs velocity and ultimately on
power generation. This will have to be delineated by assessing the
effect of ONOO− on the force–velocity and force–power relation-
ships of myosin in vitro. It should also be noted that the concen-
trations used in this and similar in vitro studies were well above
the levels believed to be reached in vivo during fatigue, further
complicating the interpretation of such studies (Allen et al., 2008).
Some of the strongest evidence for the role of ROS in fatigue
comes from the observations that the progression of fatigue can
be greatly slowed (Moopanar and Allen, 2005). In addition, in
muscle that has been severely fatigued exposure to a ROS scav-
enger can readily reverse much of the loss in force generating
capacity (Moopanar and Allen, 2006). The reversibility of these
changes suggests they are only transient structural modiﬁcations
but the speciﬁc nature of these modiﬁcations, such as the proteins
modiﬁed and the nature of the structural changes are not yet clear.
Moopanar and Allen studied the effects of fatiguing levels of
ROS on single ﬁber contractile properties and observed that this
level caused a signiﬁcant depression in force. Measures of intra-
cellular Ca++ enabled them to attribute much of the depressive
effect of ROS to an alteration in the Ca++-sensitivity, suggest-
ing the involvement of TnTm. In support of this notion, Snook
et al. (2008) recently presented evidence that ROS can directly
affect Tn/Tm function slowing velocity in an in vitro motility assay
(Snook et al., 2008). In this experiment when both themyosin and
the regulated ﬁlaments (Actin+Tn+Tm) were pretreated with
peroxynitriteONOO− the effects onV actin weremorepronounced
than that observed when myosin alone was treated, suggesting in
addition to myosin Tn/Tm are modiﬁed and functional altered by
ONOO−. Interestingly, the depressive effects using reconstituted
thin ﬁlaments (Snook et al., 2008) were less pronounced than in
muscle ﬁbers (Moopanar and Allen, 2005) suggesting that other
as yet unidentiﬁed factors may be contributing in in vivo muscle.
Thus the role of ROS in fatigue is beginning to be explored
but future efforts will have to determine whether the ultimate
effects on muscular performance in an in vivo setting are bene-
ﬁcial or detrimental. Other key issues to resolve related to ROS
and fatigue include the determination of the actual concentration
of ROS reached during fatigue and whether the structural alter-
ations induced by ROS are readily reversed in a live cell where
antioxidants and other natural reducing agents exist to reverse the
changes to structure and function.
ADDITIONAL STRUCTURAL MODIFICATIONS
In addition, to the transient changes induced by ROS and NO
species theremay also be longer lasting structural modiﬁcations to
the contractile proteins that occur during fatigue that in some cases
may be secondary to ROS damage. For example, when diaphragm
strips are repeatedly contracted under hypoxic conditions there
is a loss of both TnI and TnC from the muscle (de Paula et al.,
2001). The authors speculated that the loss might be due to cleav-
age and degradation of TnI and TnC during the fatigue and that
these structural changes contributed to the loss in force. Further-
more, much of the loss in force was reversed when full-length
exogenous TnI and TnC was added back into the fatigued ﬁbers
(de Paula et al., 2001), adding further support that the cleavage of
these proteins is responsible for the reduction in force. While they
could not identify what caused the cleavage the authors speculated
that it may stem from increased ROS production directly damag-
ing the proteins. This hypothesis could be tested by repeating the
experiments in the presence of a reducing agent to determine if it
prevents the degradation of TnTm and the associated loss in force.
This kind of cleavage and degradation of the regulatory proteins
is similar to the response observed in cardiac muscle following a
transient ischemia/reperfusion injury (a.k.a. myocardial stunning;
Gao et al., 1996). This verywell-characterized phenomenon results
in a progressive cleavage of TnI which is dependent on the severity
of the injury, and is linked to a loss in Ca++-sensitivity (McDo-
nough et al., 1999). Thus a similar phenomenonmay be occurring
duringhypoxic fatigue,althoughmore investigationwill be needed
to conﬁrm that this effect occurs during fatigue in vivo.
Phosphorylation of contractile proteins can also be classed as
a transient structural modiﬁcation, as it is a covalent modiﬁca-
tion of a protein. One particular phosphorylation event related
to fatigue that has been the focus of considerable effort is the
contraction-induced phosphorylation of myosin’s regulatory light
chain (RLC). Phosphorylation of myosin’s RLC increases with
repeated contractions and thus is high during fatigue from intense
contractile activity. These observations led Karatzaferi et al. (2008)
to examine the effects of Pi and H+ on single ﬁber contractile
properties at high and low levels of RLC phosphorylation. Inter-
estingly, they found that at physiological temperatures, elevated
levels of Pi and H+ had their greatest depressive effect on single
ﬁber force and velocity when the RLC was highly phosphorylated
as they suggested would be the case during fatigue (Karatzaferi
et al., 2008). However knocking out the light-chain phosphorylat-
ing kinase (MLCK) in a mouse model does not seem to prevent
or even attenuate the decrease in tetanic force with fatigue, sug-
gesting little or no role for this phosphorylation event in fatigue.
Although the temperatures of the two studies were different (30 vs
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25˚C) could help explain a portion of the discrepancy, the power
of the later in vivo work strongly suggests a limited or non-existent
role forMLC phosphorylation in fatigue. A similar conclusion was
reached by Greenberg et al. (2010) based ﬁndings from an in vitro
motility assay where elevated levels of H+, Pi and ADP had a simi-
lar depressive effect on the phosphorylated and dephosphorylated
myosin. Therefore while it is clear phosphorylation of MLC inﬂu-
ences tetanic force it is not clear that it has a signiﬁcant role in
fatigue.
In addition to the RLC of myosin there are amany other poten-
tial phosphorylation sites on other contractile proteins, thus this
may not be the only phosphorylation of contractile proteins asso-
ciated with fatigue. One particularly interesting phosphorylation
linked to oxidative stress in skeletal muscle, and thus possibly
fatigue, is the phosphorylation of Tm (Houle et al., 2003). In
response to elevated levels of H2O2 Houle et al. (2003) were able
to detect an increase in the phosphorylation of Tm. In subsequent
experiments it was demonstrated that in vitro phosphorylation of
Tmcan greatly increase the force and velocity of actin reconstituted
with Tm in a laser trap assay (Rao et al., 2009). Interestingly, the
results suggested that the effect was due to an increase in the size of
the cooperative unit of the thin ﬁlament, implying that phospho-
rylation modiﬁes the behavior of Tm on actin to promote strong
actomyosin binding and ultimately activation of the thin ﬁlament.
While such a change in Tm phosphorylation might occur during
fatigue the increase force and velocity observed in vitro suggests
this effectmight help to prevent the loss of muscle function during
fatigue rather that exacerbate it. However, more work will need to
be done to deﬁnitely determine the role of this and other contrac-
tion dependent changes in phosphorylation in fatigue in vivo. In
related work in the future it will be crucial to be able to link the
structural modiﬁcations to the function changes. This will likely
take a systemic approach to both locate each modiﬁcation and
assess its impact on the function of various contractile proteins in
an in vitro setting.
CONCLUSIONS AND FUTURE DIRECTIONS
The cause of fatigue has been a fundamental question of science
formany years and the cause of muscle fatigue speciﬁcally has been
studied for more than 100 years. While understanding the limits
of human performance drove much of the early efforts in this
ﬁeld it is now clear that identifying the molecular causes will have
important clinical relevance to conditions such as chronic heart
failure and ischemic heart disease where the effects of fatigue can
be severe enough to limit the daily tasks required for independent
living (Poole-Wilson and Buller, 1988). Many of the originally
proposed mechanisms, established decades ago, are now able to
be directly tested and challenged with the recent technological
developments in molecular and structural biology as well as sin-
gle molecule biophysics. These recent ﬁndings have conﬁrmed
some long-held theories but others have been sharply challenged
by the ﬁrst direct evidence. And maybe more importantly, the
new ﬁndings are presenting the ﬁeld with a new set of ques-
tions about the nature of the mechanism of fatigue, forcing us
to think at an even more basic level about the process of fatigue.
Thus it is a particularly exciting time to be studying this ques-
tion as the rapid pace of technological advances will now allow
the ﬁeld to push our knowledge even further in the very near
future.
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